Results 241 to 250 of about 945,289 (264)
Some of the next articles are maybe not open access.
BJOG : an international journal of obstetrics and gynaecology, 2001
To compare the effectiveness and safety of the oxytocin antagonist atosiban with conventional beta-adrenergic agonist (beta-agonist) therapy in the treatment of preterm labour.Three multinational, multicentre, double-blind, randomised, controlled trials. Setting Hospitals in Australia, Canada, Czech Republic, Denmark, France, Israel, Sweden, and the UK.
openaire +1 more source
To compare the effectiveness and safety of the oxytocin antagonist atosiban with conventional beta-adrenergic agonist (beta-agonist) therapy in the treatment of preterm labour.Three multinational, multicentre, double-blind, randomised, controlled trials. Setting Hospitals in Australia, Canada, Czech Republic, Denmark, France, Israel, Sweden, and the UK.
openaire +1 more source
Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 2022
Hua Kuang, Chuanlai Xu, Aihong Wu
exaly
Hua Kuang, Chuanlai Xu, Aihong Wu
exaly
In Utero Beta 2 Adrenergic Agonist Exposure and Adverse Neurophysiologic and Behavioral Outcomes
American Journal of Obstetrics and Gynecology, 2009Andrew W Zimmerman +2 more
exaly
Are Beta 3 Adrenergic Agonists Now the Preferred Pharmacologic Management of Overactive Bladder?
Current Urology Reports, 2020Lysanne Campeau +2 more
exaly
Beta-Adrenergic Agonists and Corticotropin Secretion.
Lancet, The, 1985Grossman, Ashley, L H Rees, S Al-Damluji
exaly
The Beta Adrenergic Agonist Isoproterenol Suppresses Voluntary Alcohol Intake in Rats
Pharmacology Biochemistry and Behavior, 1989E Perlanski, L A Grupp, R B Stewart
exaly

